Safety and Tolerability of Inhaled Nitric Oxide in Patients With Cystic Fibrosis

Clinical trial NCT00570349 · COMPLETED

Trial details

NCT number: NCT00570349
Sponsor: Mallinckrodt
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Cystic Fibrosis

Start date: 2004-07-01
Primary completion: 2008-12-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.